<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19946781</PMID>
        <DateCompleted>
            <Year>2010</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-1459</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>257</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurology</Title>
                <ISOAbbreviation>J. Neurol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.</ArticleTitle>
            <Pagination>
                <MedlinePgn>721-7</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-009-5396-8</ELocationID>
            <Abstract>
                <AbstractText>We recently developed a novel PET tracer, (11)C-labeled 2-(2-[2-dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole ([(11)C]BF-227), and had success with in vivo detection of amyloid plaques in Alzheimer's disease (AD) brains (Kudo et al. in J Nucl Med 8:553-561, 2007). We applied this tracer to subjects with mild cognitive impairment (MCI) and AD in order to elucidate the status of amyloid plaque deposition in MCI and compared the diagnostic performance of BF-227-PET with that of FDG-PET in AD cases. We studied 12 aged normal (AN) subjects, 15 MCIs and 15 ADs with PET using [(11)C]BF-227. PET images were obtained after administration of BF-227 and the regional standardized uptake value (SUV) and the ratio of regional to cerebellar SUV were calculated as an index of BF-227 binding. AD patients showed increased uptake of [(11)C]BF-227 in the neocortical areas and striatum as well as decreased glucose metabolism in temporoparietal, posterior cingulate and medial temporal areas. MCI subjects showed a significant increase in BF-227 uptake in the neocortical areas similar to AD, and the most significant difference of BF-227 retention was observed in the parietal lobe if its retentions for MCI were compared to those for AD and AN. On the other hand, glucose hypometabolism in MCI was confined to cingulate and medial temporal cortices. Neocortical BF-227 uptake negatively correlated with glucose metabolism. Receiver operating characteristic (ROC) analysis indicated higher specificity and sensitivity with BF-227-PET than those with FDG-PET for differential diagnosis between AD and normal control. We conclude that [(11)C]BF-227-PET has a possibility to be a useful technology for early detection of AD pathology and also even in the MCI stage.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Furukawa</LastName>
                    <ForeName>Katsutoshi</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai 980-8498, Japan. kfurukawa-ns@umin.ac.jp</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okamura</LastName>
                    <ForeName>Nobuyuki</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tashiro</LastName>
                    <ForeName>Manabu</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Waragai</LastName>
                    <ForeName>Masaaki</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Furumoto</LastName>
                    <ForeName>Shozo</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iwata</LastName>
                    <ForeName>Ren</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yanai</LastName>
                    <ForeName>Kazuhiko</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kudo</LastName>
                    <ForeName>Yukitsuka</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arai</LastName>
                    <ForeName>Hiroyuki</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>J Neurol</MedlineTA>
            <NlmUniqueID>0423161</NlmUniqueID>
            <ISSNLinking>0340-5354</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C516779">2-(2-(2-dimethylaminothiazol-5-yl)ethenyl)-6-(2-(fluoro)ethoxy)benzoxazole</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000682">Amyloid</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001583">Benzoxazoles</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D002250">Carbon Radioisotopes</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0Z5B2CJX4D</RegistryNumber>
                <NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>IY9XDZ35W2</RegistryNumber>
                <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001583" MajorTopicYN="Y">Benzoxazoles</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002250" MajorTopicYN="N">Carbon Radioisotopes</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013844" MajorTopicYN="Y">Thiazoles</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2009</Year>
                <Month>06</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2009</Year>
                <Month>08</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19946781</ArticleId>
            <ArticleId IdType="doi">10.1007/s00415-009-5396-8</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2001 Sep 11;98 (19):10966-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11526211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2001 Feb;25(2):447-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11294488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2003 Apr 22;60(8):1374-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12707450</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurocase. 2005 Feb;11(1):14-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15804920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nucl Med. 2007 Aug;48(8):1289-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17631544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nucl Med. 2007 Apr;48(4):553-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17401091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2002 Jul 19;297(5580):353-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12130773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Dec 21;355(25):2652-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17182990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 1993 Nov-Dec;14(6):589-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8295661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Neurol. 2006 May;63(5):665-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16682536</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Neurol. 2005 Feb;62(2):196-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15710847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Neurol. 1999 Mar;56(3):303-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10190820</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Radiol. 2007 Dec;80 Spec No 2:S160-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18445746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2007 May 8;68(19):1603-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17485647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2008 Oct;29(10 ):1456-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17499392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Neurol. 2006 May;63(5):674-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16682537</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1997 Jul;42(1):85-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9225689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Intern Med. 2004 Sep;256(3):183-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15324362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 1996 Jul 15;16(14):4491-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8699259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2004 Mar;55(3):306-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14991808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1999 Mar;45(3):358-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10072051</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12764551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 1994 Jul;13(1):45-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8043280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1984 Jul;34(7):939-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6610841</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>